-transparent.png){kind=logo}
Preparations of human alpha- and gamma-interferon differing by the method of production and purification had different capacity of activating phagocytosis of blood polymorphonuclear leukocytes from patients with dermatoses. Native preparations of alpha- and gamma-interferon had the highest phagocytosis-activating potency. A high level of this activity was also demonstrated with human leukocyte interferon II for injections purified by highly specific methods. A concentrated preparation of human leukocyte interferon for injections with a specific activity above 1 million IU/1 mg of protein and recombinant alpha 2-interferon (reaferon) exhibited minimal phagocytosis activating effect.
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
August 1985,
Infection and immunity,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
January 1982,
Nihon rinsho. Japanese journal of clinical medicine,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
January 1986,
Voprosy virusologii,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
July 1985,
Virology,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
January 1990,
Voprosy virusologii,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
August 1983,
The Journal of general virology,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
August 1984,
Scandinavian journal of immunology,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
November 1990,
Nucleic acids research,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
February 1985,
The Journal of clinical investigation,
N S Vakhrameeva, and
Zh E Avdeeva, and
V P Kuznetsov, and
E V Bobkova, and
O R Krylov
January 1985,
Voprosy virusologii,
